Back

Comparing the risk of cerebrovascular events in atrial fibrillation patients without chronic kidney disease or with late stage chronic kidney disease who were treated with warfarin

11 April 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Atrial Fibrillation Stroke Prevention EAPC Premium Access EuroPrevent 2019

About the speaker

Photo
Doctor Pongsakorn Buraphat

Siriraj Hospital of Mahidol University, Bangkok (Thailand)

6 More presentations in this session

Presentation thumbnail
Cognitive impairment is more frequent in hypertensive patients with atrial fibrillation than in patients with sinus rhythm
Assistant Professor M. German-Sallo (Targu Mures, RO)
Abstract Slides
Presentation thumbnail
Our hopes, our dreams and reality - Control of anticoagulant therapy in atrial fibrillation in real clinical practice
Doctor A. Zarudsky (Belgorod, RU)
Abstract
Presentation thumbnail
A study on the prevalence, predictive factors and recurrence of postoperative atrial fibrillation during early cardiac rehabilitation
Doctor N. Homorodi (Debrecen, HU)
Abstract
Presentation thumbnail
Predictors of maintenance of normal sinus rhythm after successful electrical cardioversion
Presentation thumbnail
Heart failure and atrial fibrillation patients - Clinical profile approach

Access the full session

Session thumbnail
Poster Session 1 - Atrial Fibrillation

The Event

Event poster

EuroPrevent 2019

11 April - 13 April 2019
You may be interested in
thumbnail
Congress Presentation
State-of-the-art lecture on stroke prevention in atrial fibrillation
thumbnail
Congress Presentation
Treatment strategies for atrial fibrillation in heart failure - discussion
thumbnail
Congress Presentation
Interactive discussion and Q&A

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources